๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Oral (E)-5-(2-Bromovinyl)-2'-Deoxyuridine In Severe Herpes Zoster

โœ Scribed by E. De Clercq, H. Degreef, J. Wildiers, G. De Jonge, A. Drochmans, J. Descamps and P. De Somer

Book ID
125716520
Publisher
BMJ Publishing Group
Year
1980
Tongue
English
Weight
284 KB
Volume
281
Category
Article
ISSN
0959-8138

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

(E)-5-(2-Bromovinyl)-2โ€ฒ-deoxyuridine (BV
(E)-5-(2-Bromovinyl)-2โ€ฒ-deoxyuridine (BVDU)
โœ Erik De Clercq ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons โš– 8 KB

## Abstract For Abstract see ChemInform Abstract in Full Text.

(E)-5-(2-bromovinyl)-2โ€ฒ-deoxyuridine (BV
(E)-5-(2-bromovinyl)-2โ€ฒ-deoxyuridine (BVDU)
โœ Erik De Clercq ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 291 KB

E)-5-(2-bromovinyl)-2 0 -deoxyuridine (BVDU, Brivudin, Zostex 1 , Zerpex 1 , Zonavir 1 ), now more than 20 years after its discovery, still stands out as a highly potent and selective inhibitor of herpes simplex virus type 1 (HSV-1) and varicella-zoster virus (VZV) infections. It has been used in th